Company / Cash per Share
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.21
FY2025
5-year range
$0.19 / $2.26
FY2021-FY2025
Trend
+10.6%
vs FY2024
Sector context
#143 of 146
Health Care
What the data says
Among 146 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 2% for cash per share. Cash per Share returned to growth in FY2025 after 3 years of decline, reaching $0.21.
Based on SEC 10-K filings.
0.21 in FY2025 with a 5-year CAGR of -14.6%.
Declined from $0.71 to $0.21 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -47.3%
- 5-Year CAGR
- -14.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 146This company $0.21 Sector average $27.70
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 10.6% year-over-year.
- Ranks #143 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.21 | +10.6% |
| FY2024 | $0.19 | -72.9% |
| FY2023 | $0.71 | -51.0% |
| FY2022 | $1.45 | -35.9% |
| FY2021 | $2.26 | +383.9% |
| FY2020 | $0.47 | +140.1% |
| FY2019 | $0.19 | +19.9% |
| FY2018 | $0.16 | -9.0% |
| FY2017 | $0.18 | -15.0% |
| FY2016 | $0.21 | -41.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026